CURB-65

Q: How is the CURB-65 score interpreted?

A CURB-65 score of 0-1 indicates low risk (30-day mortality 0.6-2.7%) and outpatient management is recommended. A score of 2 indicates moderate risk (~6.8% mortality) and warrants consideration for hospitalization. A score of 3 or higher indicates severe to very severe risk (14-40% mortality) requiring hospitalization, with scores 4-5 strongly suggesting ICU admission for aggressive IV antibiotic therapy and supportive care.

Q: What does each letter in CURB-65 stand for?

C stands for Confusion — new-onset confusion or disorientation (1 pt). U stands for Urea — blood urea >7 mmol/L or BUN >20 mg/dL indicating renal impairment (1 pt). R stands for Respiratory rate — tachypnea with ≥30 breaths per minute (1 pt). B stands for Blood pressure — hypotension with systolic <90 mmHg or diastolic ≤60 mmHg (1 pt). 65 stands for age 65 years or older (1 pt). Each criterion is equally weighted at 1 point.

Q: What is the difference between CURB-65 and CRB-65?

CRB-65 is a simplified version of CURB-65 that omits the urea (U) laboratory criterion, making it suitable for primary care and emergency triage settings where blood test results may not be immediately available. CRB-65 scores range from 0 to 4. A CRB-65 score of 0 suggests low risk and outpatient treatment, while a score of 3 or more indicates severe pneumonia requiring urgent hospital admission.

Q: How accurate is the CURB-65 score?

The CURB-65 score has been extensively validated in multiple international studies of community-acquired pneumonia. The 30-day mortality rates associated with each score are well-established: score 0 (~0.6%), score 1 (~2.7%), score 2 (~6.8%), score 3 (~14.0%), score 4 (~27.5%), and score 5 (~40.0%). The score demonstrates good discriminative ability with an AUROC of approximately 0.82 for predicting mortality. The Pneumonia Severity Index (PSI) offers finer granularity but requires more data points.

Q: Can I rely on this calculator for medical decisions?

No. This calculator is for educational and clinical reference purposes only. The CURB-65 score is a clinical decision aid and should not replace comprehensive medical evaluation by a qualified healthcare professional. Treatment decisions must consider the full clinical picture including patient history, comorbidities, vital signs trends, imaging findings, and local antibiotic resistance patterns.

Q: When should CURB-65 be used instead of PSI or SMART-COP?

CURB-65 is preferred in emergency departments and primary care for its simplicity — it requires only five parameters, all readily available on initial assessment. The Pneumonia Severity Index (PSI) uses 20 variables and is better for stratifying low-risk patients but is more cumbersome. SMART-COP is designed specifically for identifying patients who need intensive respiratory or vasopressor support and includes additional parameters like pH, oxygenation, and serum albumin. Choose the tool based on clinical context and available resources.

Q: What are the limitations of the CURB-65 score?

CURB-65 has several limitations: it was derived from a UK hospital cohort and may perform differently in other populations; it does not account for important factors such as hypoxia, multilobar involvement on chest X-ray, pleural effusion, comorbid conditions like chronic lung disease or immunosuppression, or socioeconomic factors affecting treatment adherence. The score may underestimate severity in younger patients without age-related risk points and can overestimate risk in the elderly solely due to age. Clinical judgment must always supplement the score.

Calculate the CURB-65 score for community-acquired pneumonia severity assessment and 30-day mortality risk using five clinical criteria with management recommendations.

Assess pneumonia severity using the CURB-65 scoring system

New-Onset Confusion (C)

Urea >7 mmol/L (BUN >20 mg/dL) (U)

Respiratory Rate ≥30/min (R)

Low Blood Pressure (Systolic <90 or Diastolic ≤60 mmHg) (B)

Age ≥65 Years (65)

About This Calculator

The CURB-65 Score Calculator is a validated clinical prediction tool used to assess the severity and 30-day mortality risk of community-acquired pneumonia (CAP). Developed by Lim and colleagues in 2003 and published in Thorax, this scoring system has become one of the most widely used clinical decision aids in respiratory medicine and emergency care worldwide.

The score evaluates five parameters — Confusion (new-onset), Urea (>7 mmol/L or BUN >20 mg/dL), Respiratory rate (≥30/min), Blood pressure (systolic <90 mmHg or diastolic ≤60 mmHg), and Age (≥65 years) — each contributing 1 point for a total score of 0 to 5. Higher scores correlate with increasing 30-day mortality, guiding clinicians on appropriate patient disposition: scores 0-1 suggest low-risk outpatient management, score 2 suggests observation or short-stay hospitalization, and scores 3-5 indicate severe pneumonia requiring hospitalization and often ICU-level care. The simplicity of CURB-65 makes it particularly valuable in emergency departments, primary care settings, and resource-limited environments where rapid triage decisions are critical.

Regional Notes

India: CURB-65 is recommended by the Indian Chest Society and National College of Chest Physicians for CAP severity assessment in Indian hospitals. The urea criterion may need adjustment for tropical chronic kidney disease patterns prevalent in certain regions. Indian ICUs frequently combine CURB-65 with the SMART-COP score for comprehensive ICU triage, especially in tertiary care centers managing severe CAP cases.

United States: The Infectious Diseases Society of America (IDSA) and American Thoracic Society (ATS) jointly recommend CURB-65 as one of several severity assessment tools for CAP. In US practice, PSI (Pneumonia Severity Index) is more commonly used in academic settings for its finer risk stratification, while CURB-65 is preferred in community emergency departments for its speed. The BUN equivalent of urea (BUN >20 mg/dL) is standard in US laboratories.

United Kingdom: CURB-65 was developed from a UK cohort study and is strongly embedded in British clinical practice. NICE guidelines (CG191) recommend CURB-65 for CAP severity assessment in adults. The CRB-65 variant (without urea) is also widely used in UK primary care settings. The British Thoracic Society (BTS) has published extensive validation data supporting its use across NHS hospitals.

This tool is intended for educational and clinical reference purposes. Always correlate scoring results with comprehensive clinical assessment, chest imaging, and laboratory investigations before making treatment decisions.

Frequently Asked Questions

What is the CURB-65 score?

CURB-65 is a validated clinical scoring system for assessing the severity and 30-day mortality risk of community-acquired pneumonia (CAP). The acronym stands for five criteria: Confusion (new-onset), Urea >7 mmol/L (or BUN >20 mg/dL), Respiratory rate ≥30/min, low Blood pressure (systolic <90 or diastolic ≤60 mmHg), and age 65 or older. Each criterion scores 1 point for a maximum of 5, guiding clinicians on patient disposition from outpatient management to ICU admission.

How is the CURB-65 score interpreted?

A CURB-65 score of 0-1 indicates low risk (30-day mortality 0.6-2.7%) and outpatient management is recommended. A score of 2 indicates moderate risk (~6.8% mortality) and warrants consideration for hospitalization. A score of 3 or higher indicates severe to very severe risk (14-40% mortality) requiring hospitalization, with scores 4-5 strongly suggesting ICU admission for aggressive IV antibiotic therapy and supportive care.

What does each letter in CURB-65 stand for?

C stands for Confusion — new-onset confusion or disorientation (1 pt). U stands for Urea — blood urea >7 mmol/L or BUN >20 mg/dL indicating renal impairment (1 pt). R stands for Respiratory rate — tachypnea with ≥30 breaths per minute (1 pt). B stands for Blood pressure — hypotension with systolic <90 mmHg or diastolic ≤60 mmHg (1 pt). 65 stands for age 65 years or older (1 pt). Each criterion is equally weighted at 1 point.

What is the difference between CURB-65 and CRB-65?

CRB-65 is a simplified version of CURB-65 that omits the urea (U) laboratory criterion, making it suitable for primary care and emergency triage settings where blood test results may not be immediately available. CRB-65 scores range from 0 to 4. A CRB-65 score of 0 suggests low risk and outpatient treatment, while a score of 3 or more indicates severe pneumonia requiring urgent hospital admission.

How accurate is the CURB-65 score?

The CURB-65 score has been extensively validated in multiple international studies of community-acquired pneumonia. The 30-day mortality rates associated with each score are well-established: score 0 (~0.6%), score 1 (~2.7%), score 2 (~6.8%), score 3 (~14.0%), score 4 (~27.5%), and score 5 (~40.0%). The score demonstrates good discriminative ability with an AUROC of approximately 0.82 for predicting mortality. The Pneumonia Severity Index (PSI) offers finer granularity but requires more data points.

Can I rely on this calculator for medical decisions?

No. This calculator is for educational and clinical reference purposes only. The CURB-65 score is a clinical decision aid and should not replace comprehensive medical evaluation by a qualified healthcare professional. Treatment decisions must consider the full clinical picture including patient history, comorbidities, vital signs trends, imaging findings, and local antibiotic resistance patterns.

When should CURB-65 be used instead of PSI or SMART-COP?

CURB-65 is preferred in emergency departments and primary care for its simplicity — it requires only five parameters, all readily available on initial assessment. The Pneumonia Severity Index (PSI) uses 20 variables and is better for stratifying low-risk patients but is more cumbersome. SMART-COP is designed specifically for identifying patients who need intensive respiratory or vasopressor support and includes additional parameters like pH, oxygenation, and serum albumin. Choose the tool based on clinical context and available resources.

What are the limitations of the CURB-65 score?

CURB-65 has several limitations: it was derived from a UK hospital cohort and may perform differently in other populations; it does not account for important factors such as hypoxia, multilobar involvement on chest X-ray, pleural effusion, comorbid conditions like chronic lung disease or immunosuppression, or socioeconomic factors affecting treatment adherence. The score may underestimate severity in younger patients without age-related risk points and can overestimate risk in the elderly solely due to age. Clinical judgment must always supplement the score.